|
1
|
Mozaffarian D, Benjamin EJ, Go AS, Arnett
DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP,
Fullerton HJ, et al: Heart Disease and Stroke Statistics-2016
Update: A report from the American Heart Association. Circulation.
133:e38–e360. 2016. View Article : Google Scholar
|
|
2
|
Diseases NCFC Report on cardiovascular
disease in China 2014. Encyclopedia of China Publishing House;
2015
|
|
3
|
White HD and Chew DP: Acute myocardial
infarction. Lancet. 372:570–584. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hochman JS, Lamas GA, Buller CE, Dzavik V,
Reynolds HR, Abramsky SJ, Forman S, Ruzyllo W, Maggioni AP, White
H, et al Occluded Artery Trial Investigators: Coronary intervention
for persistent occlusion after myocardial infarction. N Engl J Med.
355:2395–2407. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Keeley EC, Boura JA and Grines CL: Primary
angioplasty versus intravenous thrombolytic therapy for acute
myocardial infarction: A quantitative review of 23 randomised
trials. Lancet. 361:13–20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
White H; Hirulog and Early Reperfusion or
Occlusion (HERO)-2 Trial Investigators: Thrombin-specific
anticoagulation with bivalirudin versus heparin in patients
receiving fibrinolytic therapy for acute myocardial infarction: The
HERO-2 randomised trial. Lancet. 358:1855–1863. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Freemantle N, Cleland J, Young P, Mason J
and Harrison J: beta Blockade after myocardial infarction:
systematic review and meta regression analysis. BMJ. 318:1730–1737.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Verma S and Strauss M: Angiotensin
receptor blockers and myocardial infarction. BMJ. 329:1248–1249.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McMurray J, Køber L, Robertson M, Dargie
H, Colucci W, Lopez-Sendon J, Remme W, Sharpe DN and Ford I:
Anti-arrhythmic effect of carvedilol after acute myocardial
infarction: Results of the Carvedilol Post-Infarct Survival Control
in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll
Cardiol. 45:525–530. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang X, Cohen MV and Downey JM: Mechanism
of cardioprotection by early ischemic preconditioning. Cardiovasc
Drugs Ther. 24:225–234. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bergmann O, Bhardwaj RD, Bernard S, Zdunek
S, Barnabé-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA,
Druid H, et al: Evidence for cardiomyocyte renewal in humans.
Science. 324:98–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Werner N, Kosiol S, Schiegl T, Ahlers P,
Walenta K, Link A, Böhm M and Nickenig G: Circulating endothelial
progenitor cells and cardiovascular outcomes. N Engl J Med.
353:999–1007. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yao EH, Fukuda N, Matsumoto T, Katakawa M,
Yamamoto C, Han Y, Ueno T, Kobayashi N and Matsumoto K: Effects of
the antioxidative β-blocker celiprolol on endothelial progenitor
cells in hypertensive rats. Am J Hypertens. 21:1062–1068. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sen S, Merchan J, Dean J, Ii M, Gavin M,
Silver M, Tkebuchava T, Yoon YS, Rasko JE and Aikawa R: Autologous
transplantation of endothelial progenitor cells genetically
modified by adeno-associated viral vector delivering insulin-like
growth factor-1 gene after myocardial infarction. Hum Gene Ther.
21:1327–1334. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dubois C, Liu X, Claus P, Marsboom G,
Pokreisz P, Vandenwijngaert S, Dépelteau H, Streb W, Chaothawee L,
Maes F, et al: Differential effects of progenitor cell populations
on left ventricular remodeling and myocardial neovascularization
after myocardial infarction. J Am Coll Cardiol. 55:2232–2243. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Higuchi T, Anton M, Dumler K, Seidl S,
Pelisek J, Saraste A, Welling A, Hofmann F, Oostendorp RA,
Gansbacher B, et al: Combined reporter gene PET and iron oxide MRI
for monitoring survival and localization of transplanted cells in
the rat heart. J Nucl Med. 50:1088–1094. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yao Y, Li Y, Ma G, Liu N, Ju S, Jin J,
Chen Z, Shen C and Teng G: In vivo magnetic resonance imaging of
injected endothelial progenitor cells after myocardial infarction
in rats. Mol Imaging Biol. 13:303–313. 2011. View Article : Google Scholar
|
|
18
|
Kupatt C, Horstkotte J, Vlastos GA,
Pfosser A, Lebherz C, Semisch M, Thalgott M, Büttner K, Browarzyk
C, Mages J, et al: Embryonic endothelial progenitor cells
expressing a broad range of proangiogenic and remodeling factors
enhance vascularization and tissue recovery in acute and chronic
ischemia. FASEB J. 19:1576–1578. 2005.PubMed/NCBI
|
|
19
|
Smart N, Risebro CA, Clark JE, Ehler E,
Miquerol L, Rossdeutsch A, Marber MS and Riley PR: Thymosin β4
facilitates epicardial neovascularization of the injured adult
heart. Ann NY Acad Sci. 1194:97–104. 2010. View Article : Google Scholar
|
|
20
|
Sosne G, Xu L, Prach L, Mrock LK, Kleinman
HK, Letterio JJ, Hazlett LD and Kurpakus-Wheater M: Thymosin beta 4
stimulates laminin-5 production independent of TGF-beta. Exp Cell
Res. 293:175–183. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan L, Guan W, Hu Y, Xiaofan Y, Songshan
X, Liya N and Yongzhe C: Recombinant thymosin β4 accelerates skin
wound healing by regulating ICAM-1, MMP-2 and LN-5. J Tissue
Engineering and Reconstructive Surgery. 163:142–145. 2008.
|
|
22
|
Bock-Marquette I, Saxena A, White MD,
Dimaio JM and Srivastava D: Thymosin β4 activates integrin-linked
kinase and promotes cardiac cell migration, survival and cardiac
repair. Nature. 432:466–472. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Smart N, Risebro CA, Melville AA, Moses K,
Schwartz RJ, Chien KR and Riley PR: Thymosin β4 induces adult
epicardial progenitor mobilization and neovascularization. Nature.
445:177–182. 2007. View Article : Google Scholar
|
|
24
|
Sosne G, Siddiqi A and Kurpakus-Wheater M:
Thymosin-β4 inhibits corneal epithelial cell apoptosis after
ethanol exposure in vitro. Invest Ophthalmol Vis Sci. 45:1095–1100.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qiu FY, Song XX, Zheng H, Zhao YB and Fu
GS: Thymosin β4 induces endothelial progenitor cell migration via
I3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol.
53:209–214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Burlacu A, Grigorescu G, Rosca AM, Preda
MB and Simionescu M: Factors secreted by mesenchymal stem cells and
endothelial progenitor cells have complementary effects on
angiogenesis in vitro. Stem Cells Dev. 22:643–653. 2013. View Article : Google Scholar :
|
|
27
|
Chang ZT, Hong L, Wang H, Lai HL, Li LF
and Yin QL: Application of peripheral-blood-derived endothelial
progenitor cell for treating ischemia-reperfusion injury and
infarction: A preclinical study in rat models. J Cardiothorac Surg.
8:332013. View Article : Google Scholar : PubMed/NCBI
|
